{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
<< Return to MSSM Home Page
Icahn School of Medicine at Mount Sinai
  • Sign In
  • Live Courses
  • Online Courses
  • RSS
  • Calendar
  • About
  • Contact Us
  • Privacy Notice
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Sign in with your MSSM ID
Sign in with your email and password
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • APRN
  • BA
  • BS
  • BS/JD
  • Bsc, MSc
  • BSCS
  • BSMP
  • BSN
  • BSN/RN
  • BSRT
  • CCRC
  • CCT
  • CMO
  • CNM
  • CPNP
  • CRNA
  • CRNP
  • CTR
  • CVT
  • DDS
  • DDS, PhD
  • DMD
  • DMin, BCC
  • DNP
  • DNP, ANP-BC, FNP-BC
  • DNP, MS, MPH, RN, FSSH
  • DNP, MS-HCDL, FNP-BC, PMGT-BC
  • DO
  • DO, FACC, FSCAI, FASE, RPVI
  • DPM
  • DPT
  • DrPH
  • EMT
  • EMT-P
  • HSI
  • HSI/BS
  • JD
  • LCSW
  • LCSW, MSW
  • LMSW
  • LNM
  • LPN
  • MA
  • MA, RN-BC, NEA-BC
  • MBA
  • MBBS
  • MD
  • MD, AGAF
  • MD, AGAF, FACG
  • MD, FAAD, FRCPC
  • MD, FACC, FACP
  • MD, FACE, FACP
  • MD, FACG
  • MD, FACOG, MFA
  • MD, FACP
  • MD, FACP, AGAF
  • MD, FACP, CCD
  • MD, FACP, FACG, FASGE
  • MD, FACP, FAHA, AGAF, FAASLD
  • MD, FACS
  • MD, FACS, FAANS
  • MD, FACS, FASCRS
  • MD, FACS, FRCST
  • MD, FACS, MBA
  • MD, FASTRO
  • MD, JD
  • MD, MACP
  • MD, MBA
  • MD, MBA, FACS, FASCRS
  • MD, MBBS
  • MD, MCR
  • MD, MHA, FACS, MAMSE
  • MD, MPA
  • MD, MPH
  • MD, MPH, FACP, FIDSA, FSHEA
  • MD, MPH, SFHM, MACP
  • MD, MS, CGC
  • MD, MS, FACS
  • MD, MSc, FACP, FACG, FAASLD, AGAF
  • MD, MSCE
  • MD, MSCR
  • MD, MSHA
  • MD, MSPH
  • MD, MTR, FAAD
  • MD, NCMP
  • MD, PhD
  • MD, PhD, FACS
  • MD, PhD, MPH
  • MD, RVT, FACS
  • MD. MS, FACS
  • MD., MS, FACS
  • MD/PhD Candidate
  • MHA
  • MPH
  • MS
  • MS, PA-C
  • MS, RN, CCRN, CNIV, NP-C
  • MSc, CGC
  • MSN
  • MSN, ACHPN, ACNS-BC, FAAN, FPCN
  • MSN, ANP, AGPCNP-BC
  • MSN, JD, RN, CEN
  • MSN,FNP-BC
  • MSPH
  • MSW
  • MSW, LCSW
  • ND
  • None
  • NP
  • OBE, MD FMedSci
  • OT
  • Other
  • OTR
  • PA
  • PA-C
  • PdD, RN
  • PharmD
  • PhD
  • PhD Candidate
  • PhD, FRS
  • PhD, NP
  • PhD, RN, ANP-BC, CHTP, AHN-C
  • Psy. D.
  • PT
  • Rabbi
  • RCES
  • RD
  • RN
  • RN, BSN
  • RN, CNRN, MSHA, MBA
  • RN, CWON, CWS
  • RN, MSN
  • RRT
  • RT
  • RTT
  • SLP
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Mount Sinai Liver Cancer Program. 15th Anniversary. “Liver Cancer: Advances in Science and Clinical Management

  • Overview
  • Register
  • Faculty
  • Brochure
  • Exhibitors
  • Sponsors
  • Support
Add to Calendar Mount Sinai Liver Cancer Program. 15th Anniversary. “Liver Cancer: Advances in Science and Clinical Management 12/11/2020 8:30:00 AM 12/11/2020 5:00:00 PM America/New_York For More Details: https://mssm.cloud-cme.com/livercancer2020 Description: Activity Learning Objectives 1) Understand the epidemiology and disparities of liver cancer in the US. 2) Review the current role of surgical and loco-regional treatments for liver cancer. 3) Critical review of molecular therapies and SBRT in the management of advanced HCC 4) Understand the molecular rationale for immune therapies in HCC. Online false MM/DD/YYYY


Date & Location
Friday, December 11, 2020, 8:30 AM - 5:00 PM EST, Online

Target Audience
Specialties - Academic/Research, Gastroenterology, General Practice, Hematology, Hepatology, Hospitalist, Internal Medicine, Liver Diseases, Multiple Specialties, Nursing, Oncology, Physician Assistant, Primary Care Physician, Radiation Oncology, Surgeon

Course Overview
Activity Learning Objectives 1) Understand the epidemiology and disparities of liver cancer in the US. 2) Review the current role of surgical and loco-regional treatments for liver cancer. 3) Critical review of molecular therapies and SBRT in the management of advanced HCC 4) Understand the molecular rationale for immune therapies in HCC.

Objectives
  1. I am able to understand the epidemiology, risk factors and clinical indications for treatment of liver cancer according to guidelines.
  2. I am able to understand the management of COVID 19 liver cancer.
  3. I am able to understand the mechanism of action of novel targeted therapies and immune therapies coming for the management of these diseases.
  4. I am able to analyze the prospects of novel therapies (combination therapies and radiation therapy) in the management of liver cancer.

Registration

This activity is complimentary:



Accreditation
The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credits
AMA PRA Category 1 Credits™ (7.00 hours), Non-Physician Attendance (7.00 hours)



It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Faculty Photos
Scott L. Friedman, MD
Fishberg Professor of Medicine, Liver Diseases and Pharmacological Sciences
Icahn School of Medicine a Mount Sinai
New York, NY
Co-Director, Faculty
Nothing to disclose
Faculty Photos
Myron E. Schwartz, MD
Clinical Director, Mount Sinai Liver Cancer Program, Director of Liver Surgery, Recanati/Miller Transplantation Institute
The Mount Sinai Hospital
New York, NY
Co-Director, Faculty
Nothing to disclose
Faculty Photos
Samuel Waxman, MD
Distinguished Service Professor of Medicine, Hematology and Medical Oncology
Icahn School of Medicine at Mount Sinai
New York, NY
Co-Director, Faculty
Nothing to disclose
Faculty Photos
Josep M. Llovet, MD, PhD
Associate Professor of Medicine, Liver Diseases
Icahn School of Medicine at Mount Sinai
New York, NY
Course Director, Faculty
Consultant/Advisor-Bayer Pharmaceuticals, Bristol-Myers Squibb, Eisai, Lilly, Merck|Consulting Fees-Bayer, Bristol-Myers Squibb, Eisai, Lilly, Celsion, Merck, Boehringer-Ingelheim, Ipsen, Glycotest, Navigant, Leerink Swan, LLC, Blueprint, Medatech, Ltd., Fortress Biotech, Spring Bank, Nucleix, Can-Fite Biopharma
Faculty Photos
Michael Buckstein, MD
Associate Professor
Icahn School of Medicine at Mount Sinai
New York, NY
Faculty
Nothing to disclose
Gregory Gores, MD, PhD
Executive Dean for Research
Mayo Clinic
Rochester, MN
Faculty
Nothing to disclose
Faculty Photos
Ernesto Guccione, PhD
Professor, Oncological Sciences
Icahn School of Medicine at Mount Sinai
New York, NY
Faculty
Consultant/Advisor-LION TCR|Compensation for Service on an Advisory Board-LION TCR|Ownership-ImmuNOA|Stocks (Not Pubically Traded)-ImmuNOA
Faculty Photos
Edward Kim, MD
Director of Interventional Oncology, Professor of Radiology and Surgery
Icahn School of Medicine at Mount Sinai
New York, NY
Faculty
Consultant/Advisor-Boston Scientific Corporation|Consultant/Advisor-Bristol-Myers Squibb|Consultant/Advisor-Roche
Faculty Photos
Amaia Lujambio, PhD
Associate Professor of Medicine, Liver Sciences, Oncological Sciences
Icahn School of Medicine at Mount Sinai
New York, NY
Faculty
Research Support-Pfizer, Inc.|Research Support-Genentech, Inc.|Consultant/Advisor-AstraZeneca|Consulting Fees-AstraZeneca
Faculty Photos
Thomas Marron, MD, PhD
Director, Early Phase Trials Unit, Tisch Cancer Institute
The Mount Sinai Hospital
New York, NY
Faculty
Research Support-Bristol-Myers Squibb|Consulting Fees-AstraZeneca|Consulting Fees-Regeneron |Consulting Fees-Boehringer Ingelheim |Genentech, Inc.|Consulting Fees
Faculty Photos
Ramon Parsons, MD
Director, Tisch Cancer Institute, Ward-Coleman Chair in Cancer Research, Director, Mount Sinai Cancer
Mount Sinai Health System
New York, NY
Faculty
Nothing to disclose
Faculty Photos
Daniela Sia, MD
Assistant Professor of Medicine, Liver Diseases
Icahn School of Medicine at Mount Sinai
New York, NY
Faculty
Nothing to disclose
Faculty Photos
Swan N. N. Thung, MD
Professor, Pathology, Molecular & Cell Based Medicine
Icahn School of Medicine at Mount Sinai
New York, NY
Faculty
Nothing to disclose
Faculty Photos
Augusto Villanueva, MD, PhD
Associate Professor, Liver Diseases, Hematology and Medical Oncology
Icahn School of Medicine at Mount Sinai
New York, NY
Faculty
Consultant/Advisor-Boehringer Ingelheim|Consultant/Advisor-FirstWord|Consultant/Advisor-MHLife|Consultant/Advisor-Gilead|Consultant/Advisor-NGM|Consultant/Advisor-Eisai, Inc.

Friday, December 11, 2020

Registration
8:30AM - 9:00AM
Welcome and Open Remarks
9:00AM - 9:10AM
Ramon Parsons, MD
Achievements of Mount Sinai Liver Cancer Program 2005-20
9:10AM - 9:40AM
Josep M. Llovet, MD, PhD
Hans Popper Lecture
9:40AM - 10:20AM
Josep M. Llovet, MD, PhD
Precision Medicine in Cholangiocarcinoma
9:40AM - 10:20AM
Gregory Gores, MD, PhD
BREAK
10:20AM - 10:40AM
Overview: From Fibrosis to Liver Cancer
10:40AM - 11:10AM
Scott L. Friedman, MD
PATHOGENESIS OF LIVER CANCER
10:40AM - 12:00PM
Scott L. Friedman, MD
Linking Pathology with Molecular Types of HCC and iCCA
11:10AM - 11:30AM
Swan N. N. Thung, MD
Rationale for Early Immunotherapy Treatment in HCC
11:30AM - 12:00PM
Thomas Marron, MD, PhD
BREAK
12:00PM - 12:40PM
Advances in the Resection and Transplantation for HCC and iCCA
12:40PM - 1:00PM
Myron E. Schwartz, MD
Management of Liver Cancer (Early-Intermediate Stage)
12:40PM - 1:40PM
Myron E. Schwartz, MD
Chemoembolization (TACE) and Radioembolization (TARE) in HCC
1:00PM - 1:20PM
Edward Kim, MD
SBRT for Early and Intermediate HCC. Where Do We Stand?
1:20PM - 1:40PM
Michael Buckstein, MD
BREAK
1:40PM - 2:00PM
Management of Liver Cancer (Advanced Stage)
2:00PM - 3:20PM
Josep M. Llovet, MD, PhD
Molecular and Immune Therapies in Advanced HCC
2:00PM - 2:30PM
Josep M. Llovet, MD, PhD
New Emerging Therapies in Cancer and HCC- Phase I Studies
2:30PM - 2:50PM
Thomas Marron, MD, PhD
State-of-the-Art Lecture: Implications of COVID-19 in the Management of HCC: ILCA Guidelines
2:50PM - 3:20PM
Augusto Villanueva, MD, PhD
BREAK
3:20PM - 3:40PM
New Perspective on the Molecular and Immune Classification of Intra and Extrahepatic Cholangiocarcinoma
3:40PM - 4:00PM
Daniela Sia, MD
Novel Targets And Pre-Clinical Models For Liver Cancer Treatment
3:40PM - 4:40PM
Samuel Waxman, MD
Wnt Signaling and Immune Response, What We Know from Experimental Models
4:00PM - 4:20PM
Amaia Lujambio, PhD
Organoids and Other Patient-derived Preclinical Models of Liver Cancer
4:20PM - 4:40PM
Ernesto Guccione, PhD
Question and Answer & Closing Remarks
4:40PM - 5:00PM
Samuel Waxman, MD

This activity is made possible in part by educational grants from:


Bristol-Myers Squibb

Celsion

Eisai

Exelixis

Merck & Co.

Thank you to the following Exhibitors:


Eisai

Exelixis

FUJIFILM Medical Systems U.S.A., Inc.

Genentech

Exelixis



ACKNOWLEDGEMENTS:

 

This activity is made possible in part by educational grants from:


Boston Scientific

Bristol-Myers Squibb

Celsion

Eisai

Exelixis

Glycotest, Inc.

Merck & Co.


If you have not set up an account with us, please do so by clicking the button above and completing the profile information.

For CME Certificate inquiries, please email [email protected]. 

If you would like to complete a CME application and have spoke to a CME coordinator about accrediting an activity

please complete a New Application Request.*

©  Icahn School of Medicine at Mount Sinai